Introduction
The human parainfluenza type 2 virus (PIV2) is grouped within the Paramyxovirus genus of the family Paramyxoviridae (Kingsbury et al., 1978) together with human parainfluenza virus types 1, 3, 4A and 4B, mumps virus, the avian Newcastle disease virus (NDV), the Sendai virus of murine origin and the simian parainfluenza virus types 5 and 41 (SV5 and SV41).
PIV2 has a major aetiological role in serious respiratory infections of young children and is associated chiefly with croup and occasional interstitial pneumonia (Kim et al., 1961; Chanock & Mclntosh, 1990) . At present there is no satisfactory vaccine available to prevent PIV2 infections.
The paramyxoviruses contain a single-stranded negative-sense RNA genome encoding the viral proteins. These are the nucleocapsid protein (NP), large (L) protein, haemagglutinin-neuraminidase (HN), fusion protein (F), matrix protein (M), phosphoprotein (P) and C/V protein (Peluso et al., 1977; Paterson et al., 1984a; Thomas et al., 1988) . In the cases of SV5 (Hiebert et al., 1985) and mumps virus (Elango et al., 1989a ) a separate mRNA codes for a small hydrophobic (SH) protein. The two membrane glycoproteins, HN and F, form spike-like projections on the outer surface of the viral membrane.
The HN protein has both receptor-binding and neuraminidase activities and the F protein is involved in fusion of viral and cellular membranes and haemolysis and is required for the intracellular spread of virus (Scheid et al., 1972; Scheid & Choppin, 1974; Merz et al., 1980) . The two surface glycoproteins of paramyxoviruses also serve as major antigens that elicit neutralizing and protective antibodies (Paterson et al., 1987; Varsanyi et al., 1987; Spriggs et al., 1988) . The F protein is synthesized as a biologically inactive precursor molecule (F0) and is cleaved by a host protease into disulphidebonded F 1 and F2 subunits, thus bestowing it with fusion activity (Scheid & Choppin, 1977) . Polypeptides of the fusion glycoprotein have also been identified in PIV2-infected cells (Cowley & Barry, 1983) and their relative sizes were estimated as 60K (F0), 46K (F1) and 22K (F2) (Ito et al., 1987) . Despite its medical importance, very little information is available on the molecular biology of PIV2 and molecular cloning and characterization of individual PIV2 genes have been reported only very recently in the literature for the HN gene (Kawano et al., 1990a; Precious et al., 1990) and the P/V gene Ohgimoto et al., 1990) .
In this paper we describe the construction of a cDNA library from PIV2 mRNA and present the complete sequences of the F gene and predicted protein. In 0000-9889 © 1991 SGM addition we compare in detail amino acid sequences of the F proteins of several paramyxovirus types, and discuss the dissimilar organization of glycoprotein genes in SV5 and mumps virus with respect to PIV2.
Methods
Cells and virus. Vero cells were propagated in Eagle's minimum essential medium supplemented with 5% foetal calf serum. The PIV2 Greer strain, originally obtained from the American Tissue Culture Collection, was plaque-purified three times and grown in Veto cells.
Isolation ofmRNA. Cells grown in roller bottles were infected with PIV2 at a multiplicity of 1 p.f.u./cell. At 8 h post-infection (p.i.) actinomycin D (5 p.g/ml) and [3H]uridine (10 p.Ci/ml) were added to the cells. The infected Vero cells were harvested at 16 h p.i., washed three times with phosphate-buffered saline, resuspended in RS buffer (10mM-Tris-HC1 pH 8.5, 10 mM-NaCI and 1.5 mM-MgC12) and diluted with two volumes of water. Nonidet P40 was added to the suspension to a final concentration of 0-5% and the mixture was incubated at 0 °C for 10 rain. The nuclei were removed by centrifugation at 2000g for 15rain. SDS solution (10%) was added to the cytoplasmic extract to a final concentration of 1%. Proteins were extracted twice with phenol followed by phenol-chloroform (1 : 1) and total RNA was precipitated with ethanol. Poly(A) ÷ RNA was purified from the total RNA by oligo(dT)-cellulose column chromatography (Maniatis et al., 1982) . RNA-dependent in vitro translations were performed using the rabbit reticulocyte system and mRNA from infected and mock-infected cells (Maniatis et al., 1982) .
Isolation ofgenomic RNA. Veto cells, forming monolayers in roller bottles, were infected with PIV2 at a multiplicity of 0.1 p.f.u./cell. At almost complete c.p.e. (24 to 26 h p.i.), supernatants were clarified at 8000 r.p.m, for 10 min (Sorvall GSA rotor), sedimented at 13 000 r.p.m. for 90 min and spun through a 30% (w/v) sucrose solution onto a 65~ sucrose cushion at 35000 r.p.m, for 90 min (Beckman SW40 rotor). The interphase was rebanded in a 10 to 60 ~ discontinuous sucrose gradient by centrifugation at 35000 r.p.m, for 90 rain. The banded virus was diluted with TNE buffer (10mM-Tris-HC1 pH 7.4, 100 mM-NaC1, 1 mM-EDTA) and pelleted at 35000 r.p.m, for 60 rain. The purified virions were incubated with 500 I~g/ml proteinase K and 0.3 ~ SDS at 56 °C for 20 rain before being extracted twice with phenol and once with phenol-chloroform. The genomic RNA was precipitated three times with ethanol and dissolved in water to a final concentration of 2 I~g/~tl. cDNA synthesis, construction and screening of PIV2 library. PIV2-specific poly(A) + RNA (5 ~tg) was used to synthesize cDNA by a modification of the method of Gubler & Hoffman (1983) using Moloney murine leukaemia virus reverse transcriptase. An EcoRI/NotI adaptor was ligated to each end of the double-stranded cDNA and the construct was inserted into the EcoRI site of plasmid pT7/T3~-I9 (BRL). Transformations of DH5~ competent cells were performed. The library of selected colonies with inactivated/~-galactosidase expression was initially screened using 32p-labelled single-stranded cDNA, which had been synthesized from mRNA of viral or cellular origin, as probes.
Northern blot analysis. Poly(A) + RNA from PIV2-infected or mockinfected Vero cells were electrophoresed on formaldehyde-agarose gels, transferred to nitrocellulose membranes and hybridized to 32p. labelled selected plasmid DNA that had been identified as containing specific gene sequences (see Results).
DNA sequencing. Purified plasmid DNA had been denatured according to the protocol of Zhang et aL (1988) and sequencing was carried out using the dideoxynucleotide chain-terminating method of Sanger et al. (1977) employing the Pharmacia T7 Sequencing kit. For DNA sequence analysis, the DNA Strider program (Marck, 1988) and for alignment of amino acid sequences Beckman's Microgenie software were used. Relative hydrophobicity was calculated according to Kyte & Doolittle (1982) .
RNA sequencing. Oligonucleotide A 5' CATACTATCATTG-GATGCAGG 3' complementary to nucleotides 105 to 85 at the 5' end of the F mRNA, and oligonucleotide B 5' AACGATTATCCGT-TAAATTTA 3' nucleotides 1788 to 1808 at the 3' end of the F mRNA, were synthesized using a Pharmacia Gene Assembler. Oligonucleotide labelling and RNA sequencing were carried out by the following modification of the method of Geliebter (1987) . Gel-purified oligonucleotide (50 ng) was labelled at the 5' end in a 10 ~tl reaction mixture containing 50 mM-Tris-HC1 pH 7-4, 10 mM-MgC12, 5 mM-DTT, 0-1 mM-spermidine, 50~tCi [32p]ATP and 5 units of polynucleotide kinase at 37 °C for 30 min. The reaction mixture was heated to 650 °C for 10 rain and used as such. Ten ng of labelled oligonucleotide A and 10 p.g of poly(A) ÷ RNA or 10 ng of labelled oligonucleotide B and 10 ~tg of genomic RNA, were heated in a 10 ~tl reaction mixture (10 mM-Tris-HC1 pH 7.4, 250 mM-KC1) at 95 °C for 3 min and cooled on ice. A sample (2.5 ~tl) of the annealed mixture was added to 3-3 ~tl of reverse transcriptase buffer (25 mM-Tris-HC1 pH 8-3, 16 mM-MgC12, 8 mM-DTT, 0.4 mM each of dATP, dCTP, dGTP and dTTP and 3 units of avian myeloblastosis virus reverse transcriptase), 1 ill of 0.25 mMddATP, ddCTP, ddGTP or ddTTP and incubated at 52 °C for 45 min. The reaction was stopped by adding sequencing stop buffer, the samples were heated to 100 °C for 3 min and 3.5 ~tl were analysed on a 6~ sequencing gel (Sanger et al., 1977) .
Results

Assignment of PIV2 cDNA clone pF403 to the fusion protein gene of parainfluenza type 2 virus
A library of cDNA clones to mRNA isolated from human PIV2-infected Vero cells was constructed. To identify clones with F protein gene specificity, we initially performed RNA sequencing using mRNA isolated from PIV2-infected cells. Polycistronic transcripts have been observed during infection with many different paramyxoviruses (Wilde et al., 1986; Paterson et al., 1984a) . When using primer 5' GAACT-GAACCCGGTGTCACGA 3' complementary to nucleotides 59 to 39 of the PIV2 HN mRNA sequence (Kawano et al., 1990a) , an additional sequence upstream of the HN sequence was obtained. Another oligonucleotide complementary to the new sequence was synthesized and used as a probe to identify clones with F protein gene specificity in the library. This oligonucleotide hybridized to pF403, which contained an insert of about 1-8 kb in size. When clone pF403 was used as a probe in Northern blot analysis (see Methods), it hybridized to three viralRNAs of about 2000, 3000 and 15000 nucleotides, but did not anneal to cellular mRNA ( Fig. 1) . It was therefore considered to be specific for PIV2. ******M*TIDS*I S* *~*.~ISS~*AMVT***Q*I G***ET * R N QLIPTR*RR** MUMPS YV******NIQ*TD *S *EFK*VTQ*~K~*SN**L*I A**INN T S PSPGSR*H*** NDV S'I****** MPKTKEA *AKAP*E*~4*_R~4*TT***** GDSIRR *Q E SVT*SGGR**R** PIVI IV LS*V* SIDLE D* *GT*QIIQ*KNL*NR**I**KDALD*QESL*TITNDT* **N DNQTS** PIV3 L* LS*I* KIED* *S *GDQQIKQ*KRL*DR*II**YDGLR*Q*DV* V*NQES NEN*DP*T*** O 108 O O 175 PIV2 AGVVVGLAALGVATAAQITAAVAIVKANANAAAINNLASSIQSTNKAVSDVIDASRTIATAVQAIQDH SV5 ****************************************************************** MUMPS **********************************--****************************** NDV I*AII*SV**********~**S*LIQ**Q***N*LR*KE**TA*IE**HE*T*GLSQL*V**G}q4*QF PIVI F*A*I*TI** ********~*GI**AE*REARKD*ALIKD**IK*HNS*ELIQRGIGEQII*LKTL**F PIV3 F*G*I*TI******S**********E*KQARSD*EK*KEA*RD*****QS*QSSIGNLIV*IKSV**Y 176
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partially conforms to the optimal consensus sequence, ~XXAUGG, for a translation start codon (Kozak, 1986) . Primer extension sequencing on the genomic RNA revealed the precise 3' end of the F gene followed by the sequence 5' CCTAAAATAAGC 3' which was identified as the 5' terminus of the HN gene (Kawano et al., 1990a) .
Predicted amino acid sequence of the F protein
The predicted amino acid sequence, shown in Fig. 2 consists of a protein of 551 amino acids with an estimated Mr of 59 586. Analogous regions found and identified in other paramyxoviruses, like mumps virus (Elango et al., 1989b) , SV5 (Paterson et al., 1984b) , and NDV (Chambers et al., 1986) are also found in the PIV2 F protein. The first 21 amino acids are of hydrophobic character and form the signal peptide sequence which is required to transport the fusion protein across the rough endoplasmic reticulum. The site of proteolytic cleavage, activating the fusion event by PIV2, consists of amino acids Lys-Thr-Arg-Gln-Lys-Arg (amino acids 101 to 106) incorporating four basic residues. At the predicted F1 amino terminus is the fusion peptide, a region of 26 very hydrophobic amino acids, Phe-Ala-Gly-Val-Val-ValGly-Leu-Ala-Ala-Leu-Gly-Val-Ala-Thr-Ala-Ala-GlnIle-Thr-Ala-Ala-Val-Ala-Ile-Val (residues 107 to 132) (Fig. 2) . The third highly hydrophobic region of 28 amino acids (residues 486 to 513), serving as the membrane anchorage domain, is located close to the predicted C terminus of the protein, leaving a hydrophilic domain of 38 residues (amino acids 514 to 551) on the cytoplasmic side of the viral membrane for possible interactions with internal viral components. The predicted amino acid sequence of the protein contains six potential N-glycosylation sites (Asn-X-Ser or Asn-XThr). Four of these sites lie on the F2 subunit and two on the F1 subunit (Fig. 2) . The positions of four glycosylation sites and 10 Cys residues (out of the 12 identified) are conserved relative to those of other paramyxovirus F proteins (Fig. 3) .
Discussion
In this paper we describe the construction of a cDNA library and identification and sequence analysis of a clone that encodes the F protein of PIV2 Greer strain. Identification of the clone was based on primer extension sequencing of the F-HN polycistronic mRNA with use of a synthetic oligonucleotide complementary to the 5' end region of the published sequence of HN mRNA . A new primer, synthesized on the basis of the nucleotide sequence upstream of the HNcoding sequence, hybridized to pF403. This clone contained an insert of 1802 nucleotides. Primer extension of mRNA from PIV2-infected cells showed that the 5' end of the F mRNA, as determined by the transcription start sequence NCCAGGCUU, was 35 bases beyond the 5' end of the cDNA clone. This sequence is similar to the mRNA 5' end sequences of SV5, mumps virus and human PIV3. Sequence similarities are equally striking for transcription end sequences of PIV2 and the three above-mentioned paramyxoviruses (Chanock & McIntosh, 1990 Fig. 4 . Determination of the 3' end sequence of the PIV2 F protein mRNA by primer extension. A 21-mer oligonucleotide was synthesized (nucleotides 1788 to 1808), 5' end-labelled with 32p as described in Methods, and used to sequence the viral RNA. The poly(A) signal region was immediately followed by the 5" end sequence of HN mRNA (Kawano ez al., 1990a) . The Y-terminal region of the F gene is in bold characters.
have a predominantly hydrophobic character and 86.8 % of its amino acid residues were hydrophobic or uncharged. The net charge of the PIV2 F protein was positive and basic residues accounted for 8% of the molecule on a molar basis. Four positively charged residues are included in the cleavage activation site (residues 101 to 106) including two single and one paired basic residues, a conformation that is most similar to that of human PIV3 (one single and one paired basic residue). The fusion peptide, at the amino terminus of the FI subunit, consists of a 26 amino acid strictly hydrophobic peptide (residues 107 to 132), a region that has been directly implicated in the fusion process (Richardson et al., 1980) . Comparison of the F protein sequences of PIV2, SV5, mumps virus, NDV, PIV1 and PIV3 (Fig. 3) shows that although F proteins of these viruses are related, they fall into two distinct groups: (i) PIV2, SV5, mumps virus and NDV and (ii) PIV1 and PIV3. On the basis of the alignment shown in Fig. 3 , it was estimated that the PIV2 F protein shares 47% identity with SV5, 40% identity with mumps virus, 33% identity with the NDV F sequence, but only 27 % identity with both PIV1 and PIV3 F proteins. Ten of the 12 cysteine residues are conserved and it is interesting to observe that the majority of these are clustered near the N terminus of the membrane anchorage region. The single and equally conserved Cys residue of the F2 subunit (amino acid 68) must be involved in the disulphide link between the F1 and F2 subunits. This conservation of intramolecular disulphide bonds is likely to be important for the structure and function of the F protein.
Of the six Asn-linked glycosylation sites, four sites share conserved positions with those of SV5 or mumps virus or NDV. There are identical Gly and Pro residue positions as well in the fusion protein sequences (Fig. 3) . Secondary structures, due to conserved positions of Gly and Pro residues, are well preserved in the F proteins particularly between positions 309 to 415, probably making up the tight stem part of the F peplomer. The intracellular region of the F1 subunits all contain highly clustered basic amino acids (varying in number from four to seven) (residues 514 to 551 of the PIV2 sequence, Fig. 3 ). The accumulation of this positive charge may be to connect the protein to internal viral components.
In previous studies the lack of cross-reactivity of PIV2 anti-HN monoclonal antibodies (MAbs) with other members of the paramyxovirus genus indicated a distant relationship between these viruses and PIV2 (Rydbeck et al., 1988; Tsurudome et al., 1989) . Cross-reactivities involving PIV2 anti-F MAbs were also restricted and only two out of six MAbs reacted with SV41 and none with eight other paramyxoviruses (Tsurudome et al., 1989) . As previously mentioned, primer extension sequencing of PIV2 viral RNA yielded the sequence of the 3' end of the F gene followed by the 5'-terminal sequence of the HN gene (Fig. 4) . The 3' end non-coding region of the PIV2 F gene is 189 nucleotides long, including several stop codons in all reading frames. This fact precludes the presence of a protein wedged between the F and HN genes.
Although the PIV2 F protein shows, on the basis of sequence homologies, the greatest relatedness to SV5 and mumps virus F proteins, the lack of the SH protein gene suggests a different evolution for PIV2. It is hoped that these findings will contribute to the development of a recombinant vaccine.
Since the submission of this paper a report describing the PIV2 (Toshiba strain) F protein gene has been published (Kawano et al., 1990b) . The PIV2 Greer and Toshiba strain F mRNA and protein sequences have 99.8 ~ identity at the nucleotide level and 99.5 ~ identity at the amino acid level. The change of the Cys residue at residue 336 in the Greer strain to Phe in the Toshiba strain is interesting.
